TRIM proteins in blood cancers

Lisa J Crawford1, Cliona K Johnston1, Alexandra E Irvine2

  • 1Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.

Insights

Tripartite motif (TRIM) proteins are crucial E3 ligases regulating cellular functions. This review highlights their significant involvement in the development and progression of various blood cancers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Post-translational modification via ubiquitination is vital for cellular processes.
  • E3 ligases, including the tripartite motif (TRIM) family, dictate ubiquitination specificity.
  • Dysregulation of TRIM proteins is linked to diverse pathologies.

Purpose of the Study:

  • To review the role of tripartite motif (TRIM) proteins in hematological malignancies.
  • To consolidate current understanding of TRIM protein involvement in blood cancers.

Main Methods:

  • Literature review of scientific articles and research papers.
  • Focus on studies investigating TRIM proteins and their association with blood cancers.

Main Results:

  • TRIM proteins are a large subfamily of E3 ligases with critical cellular functions.
  • Evidence links TRIM protein dysregulation to various diseases, particularly blood cancers.

Conclusions:

  • TRIM proteins represent a significant area of research in hematologic oncology.
  • Further investigation into TRIM proteins may reveal novel therapeutic targets for blood cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K